Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
8.70
-0.64 (-6.85%)
Jul 24, 2026, 3:17 PM EDT - Market open

Vir Biotechnology Revenue

Vir Biotechnology had revenue of $-29.00K in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to $65.50M, up 213.96% year-over-year. In the year 2025, Vir Biotechnology had annual revenue of $68.56M, down -7.61%.

Revenue (ttm)
$65.50M
Revenue Growth
+213.96%
P/S Ratio
22.56
Revenue / Employee
$178,460
Employees
367
Market Cap
1.47B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202568.56M-5.65M-7.61%
Dec 31, 202474.21M-11.98M-13.90%
Dec 31, 202386.18M-1.53B-94.67%
Dec 31, 20221.62B520.38M47.51%
Dec 31, 20211.10B1.02B1,334.39%
Dec 31, 202076.37M68.28M843.86%
Dec 31, 20198.09M-2.58M-24.16%
Dec 31, 201810.67M7.96M293.94%
Dec 31, 20172.71M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Sarepta Therapeutics2.18B
Innoviva420.69M
AnaptysBio232.39M
Xencor97.36M
Zymeworks81.26M
Septerna72.26M
Recursion Pharmaceuticals66.41M
Intellia Therapeutics66.09M
Revenue Rankings